# A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

> **NCT01364974** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 48 (actual)

## Conditions studied

- Healthy Subjects
- Pharmacokinetics of ASP015K
- Pharmacodynamics

## Interventions

- **DRUG:** ASP015K
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01364974
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2011-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01364974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01364974, "A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01364974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*